Global RNA-based Biopharmaceuticals Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global RNA-based Biopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNA-based Biopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNA-based Biopharmaceuticals market in any manner.
Global RNA-based Biopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Market Segmentation (by Type)
Therapeutics
Vaccines
Market Segmentation (by Application)
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNA-based Biopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global RNA-based Biopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNA-based Biopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNA-based Biopharmaceuticals market in any manner.
Global RNA-based Biopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Market Segmentation (by Type)
Therapeutics
Vaccines
Market Segmentation (by Application)
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the RNA-based Biopharmaceuticals Market
- Overview of the regional outlook of the RNA-based Biopharmaceuticals Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNA-based Biopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of RNA-based Biopharmaceuticals
1.2 Key Market Segments
1.2.1 RNA-based Biopharmaceuticals Segment by Type
1.2.2 RNA-based Biopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNA-BASED BIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RNA-based Biopharmaceuticals Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global RNA-based Biopharmaceuticals Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNA-BASED BIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Global RNA-based Biopharmaceuticals Sales by Manufacturers (2019-2024)
3.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.3 RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global RNA-based Biopharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Manufacturers RNA-based Biopharmaceuticals Sales Sites, Area Served, Product Type
3.6 RNA-based Biopharmaceuticals Market Competitive Situation and Trends
3.6.1 RNA-based Biopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest RNA-based Biopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RNA-BASED BIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 RNA-based Biopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RNA-BASED BIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RNA-BASED BIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2019-2024)
6.3 Global RNA-based Biopharmaceuticals Market Size Market Share by Type (2019-2024)
6.4 Global RNA-based Biopharmaceuticals Price by Type (2019-2024)
7 RNA-BASED BIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNA-based Biopharmaceuticals Market Sales by Application (2019-2024)
7.3 Global RNA-based Biopharmaceuticals Market Size (M USD) by Application (2019-2024)
7.4 Global RNA-based Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
8 RNA-BASED BIOPHARMACEUTICALS MARKET SEGMENTATION BY REGION
8.1 Global RNA-based Biopharmaceuticals Sales by Region
8.1.1 Global RNA-based Biopharmaceuticals Sales by Region
8.1.2 Global RNA-based Biopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America RNA-based Biopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe RNA-based Biopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America RNA-based Biopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer RNA-based Biopharmaceuticals Basic Information
9.1.2 Pfizer RNA-based Biopharmaceuticals Product Overview
9.1.3 Pfizer RNA-based Biopharmaceuticals Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer RNA-based Biopharmaceuticals SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Roche
9.2.1 Roche RNA-based Biopharmaceuticals Basic Information
9.2.2 Roche RNA-based Biopharmaceuticals Product Overview
9.2.3 Roche RNA-based Biopharmaceuticals Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche RNA-based Biopharmaceuticals SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Sanofi-Aventis
9.3.1 Sanofi-Aventis RNA-based Biopharmaceuticals Basic Information
9.3.2 Sanofi-Aventis RNA-based Biopharmaceuticals Product Overview
9.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Product Market Performance
9.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals SWOT Analysis
9.3.5 Sanofi-Aventis Business Overview
9.3.6 Sanofi-Aventis Recent Developments
9.4 Abbott Laboratories
9.4.1 Abbott Laboratories RNA-based Biopharmaceuticals Basic Information
9.4.2 Abbott Laboratories RNA-based Biopharmaceuticals Product Overview
9.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Product Market Performance
9.4.4 Abbott Laboratories Business Overview
9.4.5 Abbott Laboratories Recent Developments
9.5 Arrowhead Pharmaceuticals
9.5.1 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Basic Information
9.5.2 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Overview
9.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Market Performance
9.5.4 Arrowhead Pharmaceuticals Business Overview
9.5.5 Arrowhead Pharmaceuticals Recent Developments
9.6 Benitec Biopharma
9.6.1 Benitec Biopharma RNA-based Biopharmaceuticals Basic Information
9.6.2 Benitec Biopharma RNA-based Biopharmaceuticals Product Overview
9.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Product Market Performance
9.6.4 Benitec Biopharma Business Overview
9.6.5 Benitec Biopharma Recent Developments
9.7 Calimmune Inc
9.7.1 Calimmune Inc RNA-based Biopharmaceuticals Basic Information
9.7.2 Calimmune Inc RNA-based Biopharmaceuticals Product Overview
9.7.3 Calimmune Inc RNA-based Biopharmaceuticals Product Market Performance
9.7.4 Calimmune Inc Business Overview
9.7.5 Calimmune Inc Recent Developments
9.8 Dicerna
9.8.1 Dicerna RNA-based Biopharmaceuticals Basic Information
9.8.2 Dicerna RNA-based Biopharmaceuticals Product Overview
9.8.3 Dicerna RNA-based Biopharmaceuticals Product Market Performance
9.8.4 Dicerna Business Overview
9.8.5 Dicerna Recent Developments
9.9 Gradalis
9.9.1 Gradalis RNA-based Biopharmaceuticals Basic Information
9.9.2 Gradalis RNA-based Biopharmaceuticals Product Overview
9.9.3 Gradalis RNA-based Biopharmaceuticals Product Market Performance
9.9.4 Gradalis Business Overview
9.9.5 Gradalis Recent Developments
9.10 Quark
9.10.1 Quark RNA-based Biopharmaceuticals Basic Information
9.10.2 Quark RNA-based Biopharmaceuticals Product Overview
9.10.3 Quark RNA-based Biopharmaceuticals Product Market Performance
9.10.4 Quark Business Overview
9.10.5 Quark Recent Developments
9.11 RXi
9.11.1 RXi RNA-based Biopharmaceuticals Basic Information
9.11.2 RXi RNA-based Biopharmaceuticals Product Overview
9.11.3 RXi RNA-based Biopharmaceuticals Product Market Performance
9.11.4 RXi Business Overview
9.11.5 RXi Recent Developments
9.12 Senesco
9.12.1 Senesco RNA-based Biopharmaceuticals Basic Information
9.12.2 Senesco RNA-based Biopharmaceuticals Product Overview
9.12.3 Senesco RNA-based Biopharmaceuticals Product Market Performance
9.12.4 Senesco Business Overview
9.12.5 Senesco Recent Developments
9.13 Silence Therapeutics
9.13.1 Silence Therapeutics RNA-based Biopharmaceuticals Basic Information
9.13.2 Silence Therapeutics RNA-based Biopharmaceuticals Product Overview
9.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Product Market Performance
9.13.4 Silence Therapeutics Business Overview
9.13.5 Silence Therapeutics Recent Developments
9.14 Silenseed
9.14.1 Silenseed RNA-based Biopharmaceuticals Basic Information
9.14.2 Silenseed RNA-based Biopharmaceuticals Product Overview
9.14.3 Silenseed RNA-based Biopharmaceuticals Product Market Performance
9.14.4 Silenseed Business Overview
9.14.5 Silenseed Recent Developments
9.15 Tekmira
9.15.1 Tekmira RNA-based Biopharmaceuticals Basic Information
9.15.2 Tekmira RNA-based Biopharmaceuticals Product Overview
9.15.3 Tekmira RNA-based Biopharmaceuticals Product Market Performance
9.15.4 Tekmira Business Overview
9.15.5 Tekmira Recent Developments
9.16 Alnylam Pharmaceuticals
9.16.1 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Basic Information
9.16.2 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Overview
9.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Market Performance
9.16.4 Alnylam Pharmaceuticals Business Overview
9.16.5 Alnylam Pharmaceuticals Recent Developments
10 RNA-BASED BIOPHARMACEUTICALS MARKET FORECAST BY REGION
10.1 Global RNA-based Biopharmaceuticals Market Size Forecast
10.2 Global RNA-based Biopharmaceuticals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe RNA-based Biopharmaceuticals Market Size Forecast by Country
10.2.3 Asia Pacific RNA-based Biopharmaceuticals Market Size Forecast by Region
10.2.4 South America RNA-based Biopharmaceuticals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of RNA-based Biopharmaceuticals by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global RNA-based Biopharmaceuticals Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of RNA-based Biopharmaceuticals by Type (2025-2030)
11.1.2 Global RNA-based Biopharmaceuticals Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of RNA-based Biopharmaceuticals by Type (2025-2030)
11.2 Global RNA-based Biopharmaceuticals Market Forecast by Application (2025-2030)
11.2.1 Global RNA-based Biopharmaceuticals Sales (Kilotons) Forecast by Application
11.2.2 Global RNA-based Biopharmaceuticals Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of RNA-based Biopharmaceuticals
1.2 Key Market Segments
1.2.1 RNA-based Biopharmaceuticals Segment by Type
1.2.2 RNA-based Biopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNA-BASED BIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RNA-based Biopharmaceuticals Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global RNA-based Biopharmaceuticals Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNA-BASED BIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Global RNA-based Biopharmaceuticals Sales by Manufacturers (2019-2024)
3.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.3 RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global RNA-based Biopharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Manufacturers RNA-based Biopharmaceuticals Sales Sites, Area Served, Product Type
3.6 RNA-based Biopharmaceuticals Market Competitive Situation and Trends
3.6.1 RNA-based Biopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest RNA-based Biopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RNA-BASED BIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 RNA-based Biopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RNA-BASED BIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RNA-BASED BIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2019-2024)
6.3 Global RNA-based Biopharmaceuticals Market Size Market Share by Type (2019-2024)
6.4 Global RNA-based Biopharmaceuticals Price by Type (2019-2024)
7 RNA-BASED BIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNA-based Biopharmaceuticals Market Sales by Application (2019-2024)
7.3 Global RNA-based Biopharmaceuticals Market Size (M USD) by Application (2019-2024)
7.4 Global RNA-based Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
8 RNA-BASED BIOPHARMACEUTICALS MARKET SEGMENTATION BY REGION
8.1 Global RNA-based Biopharmaceuticals Sales by Region
8.1.1 Global RNA-based Biopharmaceuticals Sales by Region
8.1.2 Global RNA-based Biopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America RNA-based Biopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe RNA-based Biopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America RNA-based Biopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer RNA-based Biopharmaceuticals Basic Information
9.1.2 Pfizer RNA-based Biopharmaceuticals Product Overview
9.1.3 Pfizer RNA-based Biopharmaceuticals Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer RNA-based Biopharmaceuticals SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Roche
9.2.1 Roche RNA-based Biopharmaceuticals Basic Information
9.2.2 Roche RNA-based Biopharmaceuticals Product Overview
9.2.3 Roche RNA-based Biopharmaceuticals Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche RNA-based Biopharmaceuticals SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Sanofi-Aventis
9.3.1 Sanofi-Aventis RNA-based Biopharmaceuticals Basic Information
9.3.2 Sanofi-Aventis RNA-based Biopharmaceuticals Product Overview
9.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Product Market Performance
9.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals SWOT Analysis
9.3.5 Sanofi-Aventis Business Overview
9.3.6 Sanofi-Aventis Recent Developments
9.4 Abbott Laboratories
9.4.1 Abbott Laboratories RNA-based Biopharmaceuticals Basic Information
9.4.2 Abbott Laboratories RNA-based Biopharmaceuticals Product Overview
9.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Product Market Performance
9.4.4 Abbott Laboratories Business Overview
9.4.5 Abbott Laboratories Recent Developments
9.5 Arrowhead Pharmaceuticals
9.5.1 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Basic Information
9.5.2 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Overview
9.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Market Performance
9.5.4 Arrowhead Pharmaceuticals Business Overview
9.5.5 Arrowhead Pharmaceuticals Recent Developments
9.6 Benitec Biopharma
9.6.1 Benitec Biopharma RNA-based Biopharmaceuticals Basic Information
9.6.2 Benitec Biopharma RNA-based Biopharmaceuticals Product Overview
9.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Product Market Performance
9.6.4 Benitec Biopharma Business Overview
9.6.5 Benitec Biopharma Recent Developments
9.7 Calimmune Inc
9.7.1 Calimmune Inc RNA-based Biopharmaceuticals Basic Information
9.7.2 Calimmune Inc RNA-based Biopharmaceuticals Product Overview
9.7.3 Calimmune Inc RNA-based Biopharmaceuticals Product Market Performance
9.7.4 Calimmune Inc Business Overview
9.7.5 Calimmune Inc Recent Developments
9.8 Dicerna
9.8.1 Dicerna RNA-based Biopharmaceuticals Basic Information
9.8.2 Dicerna RNA-based Biopharmaceuticals Product Overview
9.8.3 Dicerna RNA-based Biopharmaceuticals Product Market Performance
9.8.4 Dicerna Business Overview
9.8.5 Dicerna Recent Developments
9.9 Gradalis
9.9.1 Gradalis RNA-based Biopharmaceuticals Basic Information
9.9.2 Gradalis RNA-based Biopharmaceuticals Product Overview
9.9.3 Gradalis RNA-based Biopharmaceuticals Product Market Performance
9.9.4 Gradalis Business Overview
9.9.5 Gradalis Recent Developments
9.10 Quark
9.10.1 Quark RNA-based Biopharmaceuticals Basic Information
9.10.2 Quark RNA-based Biopharmaceuticals Product Overview
9.10.3 Quark RNA-based Biopharmaceuticals Product Market Performance
9.10.4 Quark Business Overview
9.10.5 Quark Recent Developments
9.11 RXi
9.11.1 RXi RNA-based Biopharmaceuticals Basic Information
9.11.2 RXi RNA-based Biopharmaceuticals Product Overview
9.11.3 RXi RNA-based Biopharmaceuticals Product Market Performance
9.11.4 RXi Business Overview
9.11.5 RXi Recent Developments
9.12 Senesco
9.12.1 Senesco RNA-based Biopharmaceuticals Basic Information
9.12.2 Senesco RNA-based Biopharmaceuticals Product Overview
9.12.3 Senesco RNA-based Biopharmaceuticals Product Market Performance
9.12.4 Senesco Business Overview
9.12.5 Senesco Recent Developments
9.13 Silence Therapeutics
9.13.1 Silence Therapeutics RNA-based Biopharmaceuticals Basic Information
9.13.2 Silence Therapeutics RNA-based Biopharmaceuticals Product Overview
9.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Product Market Performance
9.13.4 Silence Therapeutics Business Overview
9.13.5 Silence Therapeutics Recent Developments
9.14 Silenseed
9.14.1 Silenseed RNA-based Biopharmaceuticals Basic Information
9.14.2 Silenseed RNA-based Biopharmaceuticals Product Overview
9.14.3 Silenseed RNA-based Biopharmaceuticals Product Market Performance
9.14.4 Silenseed Business Overview
9.14.5 Silenseed Recent Developments
9.15 Tekmira
9.15.1 Tekmira RNA-based Biopharmaceuticals Basic Information
9.15.2 Tekmira RNA-based Biopharmaceuticals Product Overview
9.15.3 Tekmira RNA-based Biopharmaceuticals Product Market Performance
9.15.4 Tekmira Business Overview
9.15.5 Tekmira Recent Developments
9.16 Alnylam Pharmaceuticals
9.16.1 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Basic Information
9.16.2 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Overview
9.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Market Performance
9.16.4 Alnylam Pharmaceuticals Business Overview
9.16.5 Alnylam Pharmaceuticals Recent Developments
10 RNA-BASED BIOPHARMACEUTICALS MARKET FORECAST BY REGION
10.1 Global RNA-based Biopharmaceuticals Market Size Forecast
10.2 Global RNA-based Biopharmaceuticals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe RNA-based Biopharmaceuticals Market Size Forecast by Country
10.2.3 Asia Pacific RNA-based Biopharmaceuticals Market Size Forecast by Region
10.2.4 South America RNA-based Biopharmaceuticals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of RNA-based Biopharmaceuticals by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global RNA-based Biopharmaceuticals Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of RNA-based Biopharmaceuticals by Type (2025-2030)
11.1.2 Global RNA-based Biopharmaceuticals Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of RNA-based Biopharmaceuticals by Type (2025-2030)
11.2 Global RNA-based Biopharmaceuticals Market Forecast by Application (2025-2030)
11.2.1 Global RNA-based Biopharmaceuticals Sales (Kilotons) Forecast by Application
11.2.2 Global RNA-based Biopharmaceuticals Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNA-based Biopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global RNA-based Biopharmaceuticals Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 7. Global RNA-based Biopharmaceuticals Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-based Biopharmaceuticals as of 2022)
Table 10. Global Market RNA-based Biopharmaceuticals Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers RNA-based Biopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers RNA-based Biopharmaceuticals Product Type
Table 13. Global RNA-based Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of RNA-based Biopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RNA-based Biopharmaceuticals Market Challenges
Table 22. Global RNA-based Biopharmaceuticals Sales by Type (Kilotons)
Table 23. Global RNA-based Biopharmaceuticals Market Size by Type (M USD)
Table 24. Global RNA-based Biopharmaceuticals Sales (Kilotons) by Type (2019-2024)
Table 25. Global RNA-based Biopharmaceuticals Sales Market Share by Type (2019-2024)
Table 26. Global RNA-based Biopharmaceuticals Market Size (M USD) by Type (2019-2024)
Table 27. Global RNA-based Biopharmaceuticals Market Size Share by Type (2019-2024)
Table 28. Global RNA-based Biopharmaceuticals Price (USD/Ton) by Type (2019-2024)
Table 29. Global RNA-based Biopharmaceuticals Sales (Kilotons) by Application
Table 30. Global RNA-based Biopharmaceuticals Market Size by Application
Table 31. Global RNA-based Biopharmaceuticals Sales by Application (2019-2024) & (Kilotons)
Table 32. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2019-2024)
Table 33. Global RNA-based Biopharmaceuticals Sales by Application (2019-2024) & (M USD)
Table 34. Global RNA-based Biopharmaceuticals Market Share by Application (2019-2024)
Table 35. Global RNA-based Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Table 36. Global RNA-based Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 37. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2019-2024)
Table 38. North America RNA-based Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe RNA-based Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 41. South America RNA-based Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa RNA-based Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer RNA-based Biopharmaceuticals Basic Information
Table 44. Pfizer RNA-based Biopharmaceuticals Product Overview
Table 45. Pfizer RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer RNA-based Biopharmaceuticals SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Roche RNA-based Biopharmaceuticals Basic Information
Table 50. Roche RNA-based Biopharmaceuticals Product Overview
Table 51. Roche RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche RNA-based Biopharmaceuticals SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Sanofi-Aventis RNA-based Biopharmaceuticals Basic Information
Table 56. Sanofi-Aventis RNA-based Biopharmaceuticals Product Overview
Table 57. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi-Aventis RNA-based Biopharmaceuticals SWOT Analysis
Table 59. Sanofi-Aventis Business Overview
Table 60. Sanofi-Aventis Recent Developments
Table 61. Abbott Laboratories RNA-based Biopharmaceuticals Basic Information
Table 62. Abbott Laboratories RNA-based Biopharmaceuticals Product Overview
Table 63. Abbott Laboratories RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Recent Developments
Table 66. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Basic Information
Table 67. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Overview
Table 68. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Arrowhead Pharmaceuticals Business Overview
Table 70. Arrowhead Pharmaceuticals Recent Developments
Table 71. Benitec Biopharma RNA-based Biopharmaceuticals Basic Information
Table 72. Benitec Biopharma RNA-based Biopharmaceuticals Product Overview
Table 73. Benitec Biopharma RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Benitec Biopharma Business Overview
Table 75. Benitec Biopharma Recent Developments
Table 76. Calimmune Inc RNA-based Biopharmaceuticals Basic Information
Table 77. Calimmune Inc RNA-based Biopharmaceuticals Product Overview
Table 78. Calimmune Inc RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Calimmune Inc Business Overview
Table 80. Calimmune Inc Recent Developments
Table 81. Dicerna RNA-based Biopharmaceuticals Basic Information
Table 82. Dicerna RNA-based Biopharmaceuticals Product Overview
Table 83. Dicerna RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Dicerna Business Overview
Table 85. Dicerna Recent Developments
Table 86. Gradalis RNA-based Biopharmaceuticals Basic Information
Table 87. Gradalis RNA-based Biopharmaceuticals Product Overview
Table 88. Gradalis RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Gradalis Business Overview
Table 90. Gradalis Recent Developments
Table 91. Quark RNA-based Biopharmaceuticals Basic Information
Table 92. Quark RNA-based Biopharmaceuticals Product Overview
Table 93. Quark RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Quark Business Overview
Table 95. Quark Recent Developments
Table 96. RXi RNA-based Biopharmaceuticals Basic Information
Table 97. RXi RNA-based Biopharmaceuticals Product Overview
Table 98. RXi RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. RXi Business Overview
Table 100. RXi Recent Developments
Table 101. Senesco RNA-based Biopharmaceuticals Basic Information
Table 102. Senesco RNA-based Biopharmaceuticals Product Overview
Table 103. Senesco RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Senesco Business Overview
Table 105. Senesco Recent Developments
Table 106. Silence Therapeutics RNA-based Biopharmaceuticals Basic Information
Table 107. Silence Therapeutics RNA-based Biopharmaceuticals Product Overview
Table 108. Silence Therapeutics RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Silence Therapeutics Business Overview
Table 110. Silence Therapeutics Recent Developments
Table 111. Silenseed RNA-based Biopharmaceuticals Basic Information
Table 112. Silenseed RNA-based Biopharmaceuticals Product Overview
Table 113. Silenseed RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Silenseed Business Overview
Table 115. Silenseed Recent Developments
Table 116. Tekmira RNA-based Biopharmaceuticals Basic Information
Table 117. Tekmira RNA-based Biopharmaceuticals Product Overview
Table 118. Tekmira RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Tekmira Business Overview
Table 120. Tekmira Recent Developments
Table 121. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Basic Information
Table 122. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Overview
Table 123. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alnylam Pharmaceuticals Business Overview
Table 125. Alnylam Pharmaceuticals Recent Developments
Table 126. Global RNA-based Biopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global RNA-based Biopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America RNA-based Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America RNA-based Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe RNA-based Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe RNA-based Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific RNA-based Biopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific RNA-based Biopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America RNA-based Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America RNA-based Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa RNA-based Biopharmaceuticals Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa RNA-based Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global RNA-based Biopharmaceuticals Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global RNA-based Biopharmaceuticals Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global RNA-based Biopharmaceuticals Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global RNA-based Biopharmaceuticals Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global RNA-based Biopharmaceuticals Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNA-based Biopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global RNA-based Biopharmaceuticals Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 7. Global RNA-based Biopharmaceuticals Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-based Biopharmaceuticals as of 2022)
Table 10. Global Market RNA-based Biopharmaceuticals Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers RNA-based Biopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers RNA-based Biopharmaceuticals Product Type
Table 13. Global RNA-based Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of RNA-based Biopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RNA-based Biopharmaceuticals Market Challenges
Table 22. Global RNA-based Biopharmaceuticals Sales by Type (Kilotons)
Table 23. Global RNA-based Biopharmaceuticals Market Size by Type (M USD)
Table 24. Global RNA-based Biopharmaceuticals Sales (Kilotons) by Type (2019-2024)
Table 25. Global RNA-based Biopharmaceuticals Sales Market Share by Type (2019-2024)
Table 26. Global RNA-based Biopharmaceuticals Market Size (M USD) by Type (2019-2024)
Table 27. Global RNA-based Biopharmaceuticals Market Size Share by Type (2019-2024)
Table 28. Global RNA-based Biopharmaceuticals Price (USD/Ton) by Type (2019-2024)
Table 29. Global RNA-based Biopharmaceuticals Sales (Kilotons) by Application
Table 30. Global RNA-based Biopharmaceuticals Market Size by Application
Table 31. Global RNA-based Biopharmaceuticals Sales by Application (2019-2024) & (Kilotons)
Table 32. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2019-2024)
Table 33. Global RNA-based Biopharmaceuticals Sales by Application (2019-2024) & (M USD)
Table 34. Global RNA-based Biopharmaceuticals Market Share by Application (2019-2024)
Table 35. Global RNA-based Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Table 36. Global RNA-based Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 37. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2019-2024)
Table 38. North America RNA-based Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe RNA-based Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 41. South America RNA-based Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa RNA-based Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer RNA-based Biopharmaceuticals Basic Information
Table 44. Pfizer RNA-based Biopharmaceuticals Product Overview
Table 45. Pfizer RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer RNA-based Biopharmaceuticals SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Roche RNA-based Biopharmaceuticals Basic Information
Table 50. Roche RNA-based Biopharmaceuticals Product Overview
Table 51. Roche RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche RNA-based Biopharmaceuticals SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Sanofi-Aventis RNA-based Biopharmaceuticals Basic Information
Table 56. Sanofi-Aventis RNA-based Biopharmaceuticals Product Overview
Table 57. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi-Aventis RNA-based Biopharmaceuticals SWOT Analysis
Table 59. Sanofi-Aventis Business Overview
Table 60. Sanofi-Aventis Recent Developments
Table 61. Abbott Laboratories RNA-based Biopharmaceuticals Basic Information
Table 62. Abbott Laboratories RNA-based Biopharmaceuticals Product Overview
Table 63. Abbott Laboratories RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Recent Developments
Table 66. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Basic Information
Table 67. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Overview
Table 68. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Arrowhead Pharmaceuticals Business Overview
Table 70. Arrowhead Pharmaceuticals Recent Developments
Table 71. Benitec Biopharma RNA-based Biopharmaceuticals Basic Information
Table 72. Benitec Biopharma RNA-based Biopharmaceuticals Product Overview
Table 73. Benitec Biopharma RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Benitec Biopharma Business Overview
Table 75. Benitec Biopharma Recent Developments
Table 76. Calimmune Inc RNA-based Biopharmaceuticals Basic Information
Table 77. Calimmune Inc RNA-based Biopharmaceuticals Product Overview
Table 78. Calimmune Inc RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Calimmune Inc Business Overview
Table 80. Calimmune Inc Recent Developments
Table 81. Dicerna RNA-based Biopharmaceuticals Basic Information
Table 82. Dicerna RNA-based Biopharmaceuticals Product Overview
Table 83. Dicerna RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Dicerna Business Overview
Table 85. Dicerna Recent Developments
Table 86. Gradalis RNA-based Biopharmaceuticals Basic Information
Table 87. Gradalis RNA-based Biopharmaceuticals Product Overview
Table 88. Gradalis RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Gradalis Business Overview
Table 90. Gradalis Recent Developments
Table 91. Quark RNA-based Biopharmaceuticals Basic Information
Table 92. Quark RNA-based Biopharmaceuticals Product Overview
Table 93. Quark RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Quark Business Overview
Table 95. Quark Recent Developments
Table 96. RXi RNA-based Biopharmaceuticals Basic Information
Table 97. RXi RNA-based Biopharmaceuticals Product Overview
Table 98. RXi RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. RXi Business Overview
Table 100. RXi Recent Developments
Table 101. Senesco RNA-based Biopharmaceuticals Basic Information
Table 102. Senesco RNA-based Biopharmaceuticals Product Overview
Table 103. Senesco RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Senesco Business Overview
Table 105. Senesco Recent Developments
Table 106. Silence Therapeutics RNA-based Biopharmaceuticals Basic Information
Table 107. Silence Therapeutics RNA-based Biopharmaceuticals Product Overview
Table 108. Silence Therapeutics RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Silence Therapeutics Business Overview
Table 110. Silence Therapeutics Recent Developments
Table 111. Silenseed RNA-based Biopharmaceuticals Basic Information
Table 112. Silenseed RNA-based Biopharmaceuticals Product Overview
Table 113. Silenseed RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Silenseed Business Overview
Table 115. Silenseed Recent Developments
Table 116. Tekmira RNA-based Biopharmaceuticals Basic Information
Table 117. Tekmira RNA-based Biopharmaceuticals Product Overview
Table 118. Tekmira RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Tekmira Business Overview
Table 120. Tekmira Recent Developments
Table 121. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Basic Information
Table 122. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Overview
Table 123. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alnylam Pharmaceuticals Business Overview
Table 125. Alnylam Pharmaceuticals Recent Developments
Table 126. Global RNA-based Biopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global RNA-based Biopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America RNA-based Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America RNA-based Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe RNA-based Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe RNA-based Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific RNA-based Biopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific RNA-based Biopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America RNA-based Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America RNA-based Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa RNA-based Biopharmaceuticals Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa RNA-based Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global RNA-based Biopharmaceuticals Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global RNA-based Biopharmaceuticals Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global RNA-based Biopharmaceuticals Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global RNA-based Biopharmaceuticals Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global RNA-based Biopharmaceuticals Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of RNA-based Biopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNA-based Biopharmaceuticals Market Size (M USD), 2019-2030
Figure 5. Global RNA-based Biopharmaceuticals Market Size (M USD) (2019-2030)
Figure 6. Global RNA-based Biopharmaceuticals Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNA-based Biopharmaceuticals Market Size by Country (M USD)
Figure 11. RNA-based Biopharmaceuticals Sales Share by Manufacturers in 2023
Figure 12. Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 13. RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market RNA-based Biopharmaceuticals Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by RNA-based Biopharmaceuticals Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global RNA-based Biopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of RNA-based Biopharmaceuticals by Type (2019-2024)
Figure 19. Sales Market Share of RNA-based Biopharmaceuticals by Type in 2023
Figure 20. Market Size Share of RNA-based Biopharmaceuticals by Type (2019-2024)
Figure 21. Market Size Market Share of RNA-based Biopharmaceuticals by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global RNA-based Biopharmaceuticals Market Share by Application
Figure 24. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 25. Global RNA-based Biopharmaceuticals Sales Market Share by Application in 2023
Figure 26. Global RNA-based Biopharmaceuticals Market Share by Application (2019-2024)
Figure 27. Global RNA-based Biopharmaceuticals Market Share by Application in 2023
Figure 28. Global RNA-based Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Figure 29. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2019-2024)
Figure 30. North America RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America RNA-based Biopharmaceuticals Sales Market Share by Country in 2023
Figure 32. U.S. RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada RNA-based Biopharmaceuticals Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico RNA-based Biopharmaceuticals Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe RNA-based Biopharmaceuticals Sales Market Share by Country in 2023
Figure 37. Germany RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific RNA-based Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Region in 2023
Figure 44. China RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America RNA-based Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 50. South America RNA-based Biopharmaceuticals Sales Market Share by Country in 2023
Figure 51. Brazil RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa RNA-based Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Region in 2023
Figure 56. Saudi Arabia RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global RNA-based Biopharmaceuticals Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global RNA-based Biopharmaceuticals Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global RNA-based Biopharmaceuticals Market Share Forecast by Type (2025-2030)
Figure 65. Global RNA-based Biopharmaceuticals Sales Forecast by Application (2025-2030)
Figure 66. Global RNA-based Biopharmaceuticals Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of RNA-based Biopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNA-based Biopharmaceuticals Market Size (M USD), 2019-2030
Figure 5. Global RNA-based Biopharmaceuticals Market Size (M USD) (2019-2030)
Figure 6. Global RNA-based Biopharmaceuticals Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNA-based Biopharmaceuticals Market Size by Country (M USD)
Figure 11. RNA-based Biopharmaceuticals Sales Share by Manufacturers in 2023
Figure 12. Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 13. RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market RNA-based Biopharmaceuticals Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by RNA-based Biopharmaceuticals Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global RNA-based Biopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of RNA-based Biopharmaceuticals by Type (2019-2024)
Figure 19. Sales Market Share of RNA-based Biopharmaceuticals by Type in 2023
Figure 20. Market Size Share of RNA-based Biopharmaceuticals by Type (2019-2024)
Figure 21. Market Size Market Share of RNA-based Biopharmaceuticals by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global RNA-based Biopharmaceuticals Market Share by Application
Figure 24. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 25. Global RNA-based Biopharmaceuticals Sales Market Share by Application in 2023
Figure 26. Global RNA-based Biopharmaceuticals Market Share by Application (2019-2024)
Figure 27. Global RNA-based Biopharmaceuticals Market Share by Application in 2023
Figure 28. Global RNA-based Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Figure 29. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2019-2024)
Figure 30. North America RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America RNA-based Biopharmaceuticals Sales Market Share by Country in 2023
Figure 32. U.S. RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada RNA-based Biopharmaceuticals Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico RNA-based Biopharmaceuticals Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe RNA-based Biopharmaceuticals Sales Market Share by Country in 2023
Figure 37. Germany RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific RNA-based Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Region in 2023
Figure 44. China RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America RNA-based Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 50. South America RNA-based Biopharmaceuticals Sales Market Share by Country in 2023
Figure 51. Brazil RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa RNA-based Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Region in 2023
Figure 56. Saudi Arabia RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa RNA-based Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global RNA-based Biopharmaceuticals Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global RNA-based Biopharmaceuticals Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global RNA-based Biopharmaceuticals Market Share Forecast by Type (2025-2030)
Figure 65. Global RNA-based Biopharmaceuticals Sales Forecast by Application (2025-2030)
Figure 66. Global RNA-based Biopharmaceuticals Market Share Forecast by Application (2025-2030)
